Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Continuous Glucose Monitoring Device Market, by Component
1.4.2 Europe Continuous Glucose Monitoring Device Market, by End User
1.4.3 Europe Continuous Glucose Monitoring Device Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Continuous Glucose Monitoring Device Market by Component
3.1 Europe Sensors Market by Country
3.2 Europe Transmitters Market by Country
3.3 Europe Receivers Market by Country
Chapter 4. Europe Continuous Glucose Monitoring Device Market by End-user
4.1 Europe Hospitals Continuous Glucose Monitoring Device Market by Country
4.2 Europe Homecare Settings Market by Country
4.3 Europe Other End Users Market by Country
Chapter 5. Europe Continuous Glucose Monitoring Device Market by Country
5.1 Germany Continuous Glucose Monitoring Device Market
5.1.1 Germany Continuous Glucose Monitoring Device Market by Component
5.1.2 Germany Continuous Glucose Monitoring Device Market by End-user
5.2 UK Continuous Glucose Monitoring Device Market
5.2.1 UK Continuous Glucose Monitoring Device Market by Component
5.2.2 UK Continuous Glucose Monitoring Device Market by End-user
5.3 France Continuous Glucose Monitoring Device Market
5.3.1 France Continuous Glucose Monitoring Device Market by Component
5.3.2 France Continuous Glucose Monitoring Device Market by End-user
5.4 Russia Continuous Glucose Monitoring Device Market
5.4.1 Russia Continuous Glucose Monitoring Device Market by Component
5.4.2 Russia Continuous Glucose Monitoring Device Market by End-user
5.5 Spain Continuous Glucose Monitoring Device Market
5.5.1 Spain Continuous Glucose Monitoring Device Market by Component
5.5.2 Spain Continuous Glucose Monitoring Device Market by End-user
5.6 Italy Continuous Glucose Monitoring Device Market
5.6.1 Italy Continuous Glucose Monitoring Device Market by Component
5.6.2 Italy Continuous Glucose Monitoring Device Market by End-user
5.7 Rest of Europe Continuous Glucose Monitoring Device Market
5.7.1 Rest of Europe Continuous Glucose Monitoring Device Market by Component
5.7.2 Rest of Europe Continuous Glucose Monitoring Device Market by End-user
Chapter 6. Company Profiles
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Product Launches and Product Expansions:
6.2 Medtronic PLC
6.2.1 Company overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Acquisition and Mergers:
6.2.5.3 Approvals:
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Acquisition and Mergers:
6.4 Novo Nordisk A/S
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental & Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Acquisition and Mergers:
6.5 DexCom, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Approvals:
6.6 Ypsomed AG
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Senseonics Holdings, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Partnerships, Collaborations, and Agreements:
6.7.5.2 Approvals:
6.8 GlySens, Incorporated
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Approvals:
6.9 A. Menarini Diagnostics Ltd. (The Menarini Group)
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.1 Echo Therapeutics, Inc.
6.10.1 Company Overview
6.11 Johnson and Johnson
6.11.1 Company Overview
6.11.2 Financial Analysis
6.11.3 Segmental &Regional Analysis
6.11.4 Research & Development Expenses
6.11.5 Recent strategies and developments:
6.11.5.1 Approvals:
Unique Offerings 